Mouse IFN-γ T cell ELISPOT antibody pair - 10-plate

SKU
CT655-10
Validated ELISPOT antibody pair; reagents available separately (960 determinations).
Format
10-plate
Price
€ 655
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Pingfei Li Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization Vaccine 2007 25 1544-51
Min Zhang Trehalose-6-phosphate Phosphatase from Mycobacterium tuberculosis induces humoral and cellular immune responses FEMS Immunol Med Microbiol 2007 49 68-74
Y Xu Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis Scand J Immunol 2006 64 476-81
Michaël Lukens V Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice Virology 2006 352 157-68
Tae-Hyung Lee Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma Immunol Lett 2006 106 19-26
Yuxia Zhang Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion Biochem Biophys Res Commun 2006 344 581-7
Anthony Cristillo Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine Virology 2006 346 151-68
Luis Martinez-Sobrido Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector J Virol 2006 80 1130-9
Yanwen Jin Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid Clin Diagn Lab Immunol 2005 12 1364-9
S Zhang DNA vaccination using bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases Scand J Immunol 2005 62 371-7